Hudecova I et al. further advanced this approach by combining ddPCR with targeted massive parallel sequencing (MPS) to assess (Factor VIII) F8 and (Factor IX) F9 gene mutations in 15 fetuses from hemophilia carriers [129]. This evidence concerns the gene F9 and hemophilia.